|
NL291628A
(enExample)
|
1962-04-17 |
|
|
|
|
US4022901A
(en)
|
1975-03-05 |
1977-05-10 |
E. R. Squibb & Sons, Inc. |
3-Pyridinyl-5-isothiocyanophenyl oxadiazoles
|
|
US4016170A
(en)
|
1975-07-28 |
1977-04-05 |
Sandoz, Inc. |
Oxadiazolyl benzamides
|
|
US4135910A
(en)
|
1977-05-12 |
1979-01-23 |
Monsanto Company |
Oxadiazol-3-yl-benzoates as plant growth regulants
|
|
US4166732A
(en)
|
1977-05-12 |
1979-09-04 |
Monsanto Company |
Oxadiazol-5-yl-benzoates
|
|
US4210762A
(en)
|
1978-08-17 |
1980-07-01 |
Monsanto Company |
2[5-(3-Trifluoromethylphenyl)-1,3,4-oxadiazol-2-yl] benzoates
|
|
US4268299A
(en)
|
1978-08-17 |
1981-05-19 |
Monsanto Company |
Method and composition for plant growth regulation containing trifluoromethyl 1,3,4 oxadiazol benzoates
|
|
US5484944A
(en)
|
1993-10-27 |
1996-01-16 |
Neurogen Corporation |
Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
|
|
TW343965B
(en)
|
1994-03-30 |
1998-11-01 |
Hoffmann La Roche |
Novel mono- and bicyclic DNA gyrase inhibitors
|
|
US6071700A
(en)
|
1995-01-20 |
2000-06-06 |
University Of Massachusetts |
Heterologous polypeptide production in the absence of nonsense-mediated MRNA decay functions
|
|
EP0853626A1
(en)
|
1995-09-07 |
1998-07-22 |
Novartis AG |
Substituted phosphinic compounds and their use as pharmaceuticals
|
|
WO1997041105A1
(en)
|
1996-04-26 |
1997-11-06 |
Nippon Soda Co., Ltd. |
Novel heterocycle-substituted benzene derivatives and herbicides
|
|
DE19620041A1
(de)
|
1996-05-17 |
1998-01-29 |
Merck Patent Gmbh |
Adhäsionsrezeptor-Antagonisten
|
|
US6034106A
(en)
|
1996-06-07 |
2000-03-07 |
Merck & Co., Inc. |
Oxadiazole benzenesulfonamides as selective β3 Agonist for the treatment of Diabetes and Obesity
|
|
JP2000511903A
(ja)
|
1996-06-07 |
2000-09-12 |
メルク エンド カンパニー インコーポレーテッド |
糖尿病および肥満の治療のための選択性β▲下３▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド
|
|
DE19626318A1
(de)
|
1996-07-01 |
1998-01-08 |
Basf Ag |
Farbstoffmischungen, enthaltend Polyazofarbstoffe
|
|
ZA98371B
(en)
|
1997-01-31 |
1999-07-16 |
Du Pont |
Genetically transformed plants demonstrating resistance to porphyrinogen biosynthesis-inhibiting herbicides.
|
|
ES2329739T3
(es)
|
1997-04-07 |
2009-11-30 |
Georgetown University |
Analogos de cocaina.
|
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
|
AU9647998A
(en)
|
1997-10-27 |
1999-05-17 |
Nippon Soda Co., Ltd. |
Novel benzoylpyrazole derivatives and herbicides
|
|
IL139187A0
(en)
|
1998-04-23 |
2001-11-25 |
Cortech Inc |
Cysteine protease inhibitors
|
|
CA2346689A1
(en)
|
1998-10-08 |
2000-04-20 |
Gregor James Macdonald |
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
|
|
EP1119568B1
(en)
|
1998-10-09 |
2004-02-18 |
Janssen Pharmaceutica N.V. |
4,5-dihydro-isoxazole derivatives and their pharmaceutical use
|
|
EP1126833A4
(en)
|
1998-10-29 |
2004-09-08 |
Trega Biosciences Inc |
OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES CONTAINING THESE DERIVATIVES
|
|
BR9916488A
(pt)
|
1998-12-23 |
2001-10-09 |
Smithkline Beecham Corp |
Inibidores de protease
|
|
AU3196200A
(en)
|
1999-03-26 |
2000-10-16 |
Shionogi & Co., Ltd. |
Beta-amino acid derivatives
|
|
WO2000058304A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Heterocyclic sulfonamide derivatives
|
|
WO2000058280A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Carbocyclic sulfonamide derivatives
|
|
AU4537900A
(en)
|
1999-05-17 |
2000-12-05 |
Agouron Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2001066534A2
(en)
|
2000-03-09 |
2001-09-13 |
Abbott Laboratories |
Cyclic and bicyclic diamino histamine-3 receptor antagonists
|
|
US6498151B2
(en)
|
2000-03-22 |
2002-12-24 |
Merck Frosst Canada & Co. |
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
|
|
AU2001248765A1
(en)
|
2000-04-21 |
2001-11-12 |
Shionogi And Co., Ltd. |
Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
DZ3347A1
(fr)
|
2000-05-22 |
2001-11-29 |
Aventis Pharma Inc |
Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase
|
|
JP2002105073A
(ja)
|
2000-09-27 |
2002-04-10 |
Shionogi & Co Ltd |
新規マトリックスメタロプロテアーゼ阻害剤
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
CA2342432A1
(en)
|
2001-03-28 |
2002-09-28 |
Christopher Norbert Johnson |
Novel compound
|
|
GB0108102D0
(en)
|
2001-03-30 |
2001-05-23 |
Pfizer Ltd |
Compounds
|
|
BR0209054A
(pt)
|
2001-04-19 |
2004-04-20 |
Bayer Ag |
Arilsulfonamidas como agentes antivirais
|
|
US7041685B2
(en)
|
2001-06-08 |
2006-05-09 |
Cytovia, Inc. |
Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
JP2003081832A
(ja)
|
2001-06-26 |
2003-03-19 |
Takeda Chem Ind Ltd |
レチノイド関連受容体機能調節剤
|
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
MY151199A
(en)
|
2001-11-02 |
2014-04-30 |
Rigel Pharmaceuticals Inc |
Substituted diphenyl heterocycles useful for treating hcv infection
|
|
CN1691944A
(zh)
|
2002-08-09 |
2005-11-02 |
阿斯利康(瑞典)有限公司 |
作为代谢型谷氨酸受体－5调节剂的噁二唑
|
|
AU2003264018A1
(en)
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
GB0303503D0
(en)
|
2003-02-14 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
AU2003901425A0
(en)
*
|
2003-03-27 |
2003-04-10 |
Bionomics Limited |
A diagnostic method for epilepsy
|
|
JP2006521344A
(ja)
|
2003-03-28 |
2006-09-21 |
ファイザー・プロダクツ・インク |
アテローム性動脈硬化症および肥満の治療のためのｃｅｔｐ阻害剤としての１，２，４−置換１，２，３，４−テトラヒドロ−および１，２−ジヒドロ−キノリンおよび１，２，３，４−テトラヒドロ−キノキサリン誘導体
|
|
EP4101846B1
(en)
|
2003-04-11 |
2023-08-02 |
PTC Therapeutics, Inc. |
1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
|
|
US20050075375A1
(en)
|
2003-05-14 |
2005-04-07 |
Anadys Pharmaceuticals, Inc. |
Heterocyclic compounds for treating hepatitis C virus
|
|
WO2005060961A2
(en)
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
US7745630B2
(en)
|
2003-12-22 |
2010-06-29 |
Justin Stephen Bryans |
Triazolyl piperidine arginine vasopressin receptor modulators
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
JP2008515992A
(ja)
|
2004-10-13 |
2008-05-15 |
ピーティーシー セラピューティクス，インコーポレーテッド |
体細胞変異に起因する疾患の阻止／治療用医薬を製造するための規定化合物の使用
|
|
AU2006235115C1
(en)
|
2005-04-08 |
2013-02-28 |
Ptc Therapeutics, Inc. |
Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
|
|
CN101193632A
(zh)
*
|
2005-04-08 |
2008-06-04 |
Ptc医疗公司 |
用于无义突变抑制治疗的口服活性1,2,4-噁二唑组合物
|
|
US20100088778A1
(en)
*
|
2005-06-16 |
2010-04-08 |
John Charles Mulley |
Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
|
|
EP2387995A1
(en)
|
2006-03-30 |
2011-11-23 |
PTC Therapeutics, Inc. |
Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
|
|
WO2007123848A2
(en)
|
2006-04-19 |
2007-11-01 |
Brown University |
Therapeutic compositions containing modified class i slrp proteins
|
|
NZ598012A
(en)
|
2006-09-08 |
2013-08-30 |
Ptc Therapeutics Inc |
Processes for the preparation of 1,2,4-oxadiazole benzoic acids
|
|
UA99600C2
(en)
|
2006-09-25 |
2012-09-10 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
|
|
US8101641B2
(en)
|
2006-09-25 |
2012-01-24 |
Ptc Therapeutics, Inc. |
Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof
|
|
KR20170100072A
(ko)
|
2006-10-12 |
2017-09-01 |
피티씨 테라퓨틱스, 인크. |
넌센스 돌연변이 억제 치료를 위한 경구 활성 1,2,4-옥사디아졸의 투여 방법
|
|
WO2008127364A2
(en)
|
2006-10-13 |
2008-10-23 |
Myriad Genetics, Inc. |
Antiviral compounds and use thereof
|
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
|
CN101970420B
(zh)
|
2007-10-04 |
2014-09-24 |
默克雪兰诺有限公司 |
噁二唑衍生物
|
|
NZ584793A
(en)
|
2007-10-26 |
2012-05-25 |
Academisch Ziekenhuis Leiden |
Means and methods for counteracting muscle disorders
|
|
EP2234625B8
(en)
|
2007-12-17 |
2013-10-30 |
The Regents of the University of Michigan |
Compositions and methods for treating and preventing skeletal muscle deficiencies
|
|
WO2010008831A2
(en)
|
2008-06-24 |
2010-01-21 |
Irm Llc |
Compounds and methods for modulating g protein-coupled receptors
|
|
AU2009302478B2
(en)
|
2008-10-07 |
2015-09-03 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
RU2398770C1
(ru)
|
2009-03-27 |
2010-09-10 |
Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) |
Меченная тритием 3-[5-(2-фторфенил)-1,2,4-оксадиазол-3-ил]бензойная кислота
|
|
EP2241558A1
(en)
*
|
2009-04-03 |
2010-10-20 |
Merck Serono SA |
Oxadiazole derivatives
|
|
WO2011072281A1
(en)
|
2009-12-11 |
2011-06-16 |
Ptc Therapeutics, Inc. |
Methods for treating methylmalonic acidemia
|
|
JP5877200B2
(ja)
*
|
2010-08-05 |
2016-03-02 |
ユニヴェルシテ ドゥ ドロワ エ サンテ ドゥ リール |
ナンセンス突然変異による疾患の治療に有用な化合物及びその化合物を含む医薬組成物
|
|
WO2015134711A1
(en)
|
2014-03-06 |
2015-09-11 |
Ptc Therapeutics, Inc. |
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
|
|
WO2015188037A1
(en)
|
2014-06-06 |
2015-12-10 |
Ptc Therapeutics, Inc. |
Methods of treatment using a 1,2,4-oxadiazole benzoic acid
|